Trends in Inflammatory Bowel Disease Therapy 1999: The Proceedings of a Symposium Organized by Axcan Pharma, Held in Vancouver, Bc, August 27-29, 1999

ISBN-13: 9789401057691 / Angielski / Miękka / 2012 / 262 str.

C. Noel Williams; R. F. Bursey; D. G. Gall

Opis

This volume is the proceedings of the symposium Trends in Inflammatory Bowel Disease Therapy 1999' held in Vancouver, Canada, August 27-29, 1999, and sponsored by the Canadian Association of Gastroenterology, The Crohn's and Colitis Foundation of Canada and Axcan Pharma. It is the seventh international IBD symposium to be held in Canada and focuses on all areas of IBD therapy. Topics include: Genetics; Pathogenesis with reference to the role of autoimmunity, bacterial factors and neutrophil-epithelial interactions; Special clinical problems such as difficult diagnoses and challenges presented by children and the elderly; Bone disease in IBD; An overview of current therapy; A discussion of alternative therapy.

Spis treści

List of Principal Authors. Preface. Section I: Genetics. 1. Genetics of Inflammatory Bowel Disease: Where Are We? K. Siminovitch. 2. Genetics of Inflammatory Bowel Disease - Why is it Important? D. Jewell. 3. Genetics of IBD: Impact on Immune Function; C. Fiocchi. Section II: Pathogenesis. 4. Bacterial Factors in Inflammatory Bowel Disease Pathogenesis; W. Doe. 5. IBD: Autoimmunity or Chronic Inflammation? L. Mayer. 6. Neutrophil-Epithelial Interactions, and Efforts to Down-Regulate Them, in Inflammatory Bowel Disease; A. Gewirtz, J.L. Madara. 7. Understanding IBD at the Millennium: Tentative Answers and Future Questions; D.K. Podolsky. Section III: Clinical Challenges in IBD. 8. Diagnosis of Inflammatory Bowel Disease - An Update; M. Robinson. 9. Recent Developments in the Diagnosis and Management of Pediatric IBD; E.G. Seidman, et al. 10. Inflammatory Bowel Disease in the Elderly; G.R. Greenberg, I. Tai. Section IV: Current Therapy in IBD. 11. Therapy for Active Ulcerative Colitis; S.B. Hanauer. 12. Remission Maintenance in Ulcerative Colitis; J. Schölmerich. 13. Induction Therapy in Crohn's Disease; A.H. Steinhart. 14. Maintenance of Remission in Crohn's Disease; R. Rutgeerts. Section V: Bone Disease in IBD. 15. Risk Factors and Prevalence of Bone Disease in IBD. C.N. Bernstein. 16. The Management of Low Bone Mass in Patients with IBD; A. Tenenhouse. 17. Steroid Induced Osteonecrosis in IBD: CanadianLegal Status; R.M. Carter, M.G.A. Grace. Section VI: Alternative Therapy. 18. Psychotherapy for Inflammatory Bowel Disease: New Prospects; R. Maunder. 19. The Use of Complementary and Alternative Medicine by Patients with Inflammatory Bowel Disease; R.J. Hilsden, M.J. Verhoef. 20. Gut Inflammation: Is There a Role for Herbal Medicines? M.J.S. Miller. 21. The Role of Nutrition in the Treatment of IBD; M.A. Gassull. Section VII: New Therapeutic Approaches. 22. Antibodies to Proinflammatory Cytokines; L.C. Karp, S.R. Targan. 23. Immunomodulation of Crohn's Disease; C. van Montfrans, et al. 24. The Application of Recombinant DNA Technology to the Identification of Novel Therapeutic Targets in Inflammatory Bowel Disease; G.E. Wild, et al. 25. The Use of Probiotics in Inflammatory Bowel Disease; M. Campieri, et al. Index.